Please turn JavaScript on
header-image

Just Patent Law Blog

Follow Just Patent Law Blog's news and updates in a matter of seconds! We will deliver any update via email, phone or you can read them from here on the site on your own news page.

You can even combine different feeds with the feed for Just Patent Law Blog.

Subscribing and unsubscribing is fast, easy and risk free.

The whole service is free of cost.

Just Patent Law Blog: Just Patent Law Blog

Publisher:  p.j.delange
Message frequency:  3.38 / week
Tags: 

Message History

Key points

  • The proprietor presented amended claims as its main request before the OD. The OD found these claims to be allowable. The opponent appeals.
  • The Board finds those claims (MR) to lack an inventive step.
  • The Board arrives at AR-1. AR-1 is a carry-over request in which a feature is replaced compared to the MR. Hence, one feature of the MR ...
  • Read full story

    Key points

  • The Board, in translation: "It was argued [by the opponent] that [auxiliary request 3 ] did not meet the requirements of Rule 80 EPC because in the set of claims of auxiliary request 3, the independent process [] claim of the patent was replaced by two independent process [] claims.
  • The board finds no violation of Rule 80 EPC. The situation is...
  • Read full story

    Key points

  • The Board, in translation: "auxiliary request 2 contains - in contrast to the granted patent, which contains only a single claim  -  three independent claims, each directed to a cosmetic oil-in-water (O/W) emulsion...
  • Read full story

    Key points

  • The opponents include "Keine Patente auf Saatgut! e.V.". The patent concerns a conventionally-bred watermelon.
  • The opponent argued that "the transitional period created by opinion G 3/19 should not be taken into account and that it did not matter whether the patent ...
  • Read full story

    Key points

  • In this appeal, the Board found the second medical use claim to be valid (novel and inventive and sufficiently disclosed in the patent). Still, the Board - obiter it seems - held that the priority was invalid because, whereas the application as filed contained the results of a clinical trial, the priority document contained only the protoc...
  • Read full story